An emission treatment system includes: an exhaust pipeline; a catalyst converter mounted in the exhaust pipeline; a photovoltaic cell disposed outwardly of the exhaust pipeline for converting light into electrical energy; and an electrical heater provided on the catalyst converter and connected electrically to the photovoltaic cell. A method for preheating a catalyst converter before activation of...

This invention relates to a regeneration device for waste volatile-organic-compound gas utilizing plasma desorption, comprising a desorption chamber, a condensing absorber, a demister, and a humidity regulator. The desorption chamber generates plasma therein for providing energy to make a waste volatile-organic-compound gas filter performing desorption reaction therein, so as to release the volati...

This invention relates to a protective covering structure of a mixer, comprising a fixing ring connected to a head of the mixer and circumferentially provided with a protruding ring; an upper rotating ring formed with a seating part for sitting on the protruding ring and provided thereon with at least two raised stopping parts spaced from each other, a recess being formed between each stopping par...

A miniaturized fluid dispensing system for dispensing customized fluids. The dispenser may include first and second reservoirs containing constituent fluids; a drive motor; at least two pump assemblies commonly driven by the drive motor and in communication with the first and second reservoirs; first and second valve assemblies in communication with the first and second pump assemblies; and a cont...

An agglomerated zeolite adsorbent which comprises 95-99.5 mass% of X zeolite and 0.5-5.0 mass% of binder, wherein the exchangeable cationic sites of said X zeolite are occupied by Group IIA metal and/or K, the total pore volume of said adsorbent is no less than 0.26 mL/g as determined by mercury porosimetry, the volume of pores with pore diameters from 100 to 500 nm is at least 60% based on the to...

An adsorber for separating a gas from an auxiliary fluid in a gas compressor (9) comprises a pressure vessel (1) which, for the purpose of separating the auxiliary fluid from the gas, contains a granulate (3) through which the mixture of gas and auxiliary fluid can flow, wherein the granulate (3) is enclosed by a filter including at least one filter element (5) and by the inner wall of the pressur...

Catalysts for the oxychlorination of ethylene to 1.2-dichloroethane, in form of hollow granules having definite geometrical configuration and pore volume distribution with at least 20% of the total volume formed of macropores wherein the diameter of the pores at the maximum of the macropore distribution curve is higher than 800 nm and up to 1500 nm.

An improved cracking catalyst is disclosed for the production of propylene from a hydrocarbon feedstock. The process uses a catalyst blend comprising a large pore catalyst and a medium or small pore catalyst, where the medium or small pore catalyst includes a metal deposited on the medium or small pore catalyst.

The present invention relates to a variation curve dynamic planning method for glue amount of a glue machine, which primarily maintains inherent physical properties with glue and glue ejecting actions, plans output pressure programs in conformity to the glue nature, and allows the pressure variations to be approximately close to a theoretical value, i.e. a value falling into the available scope of...

A coating device includes a precursor solution-preparing apparatus and a deposition apparatus. The precursor solution-preparing apparatus includes a liquid-storage tank, a vaporization unit and an absorbing tower. The liquid-storage tank and the vaporization unit are all connected with the absorbing tower. The liquid-storage tank is used for storing coating solution and providing the absorbing tow...

Pharmaceutical composition containing a combination of a non steroidal anti inflammatory drug and a colchicoside derivative, the active ingredients being present in the free state or in the form of a salt.

There is provided a film coated pharmaceutical composition comprising 5'-deoxy-5-fluoro-N-[(pentyloxy)-carbonyl]-cytidine (capecitabine) and at least one disintegrant selected from the group comprising of crospovidone (particle size < 15-400 μ ), croscarmellose sodium, sodium starch glycolate, low-substituted hydroxypropylcellulose, Ludiflash ® or any combination of these, together with other phar...

The invention provides a Pyracantha koidzumii extract and new compounds isolated from the extract and their derivatives. This extract and these compounds have activity in inhibiting tyrosinase.

A coffea arabica leaf extract and its extraction method and uses are provided. The extract is useful for inhibiting the activity and/or expression of matrix metalloproteinase (MMP), inhibiting the phosphorylation of mitogen-activated protein kinase (MAPK), and/or promoting the expression of collagen.

The present invention provides an extract of Taiwan wild grape (Vitis thunbergii var. taiwaniana), which is prepared by extracting with alcohol solution of 10 wt% to 100 wt% or water, and then drying. The extract of Taiwan wild grape of the present invention has the function of regulating blood pressure, and therefore can be used to prevent and treat high blood pressure. The present invention also...

A michelia alba leaf extract and its extraction method and uses are provided. The extract is useful for inhibiting the activity and/or expression of matrix metalloproteinase (MMP), and/or inhibiting the phosphorylation of mitogen-activated protein kinase (MAPK).

The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacteria, including resistant strains. The compounds are useful as antibacterial agents against Clostridium difficile.

Prodrug formulations of glucagon superfamily peptides are provided wherein the glucagon superfamily peptide has been modified by the linkage of a dipeptide to the glucagon superfamily through an amide bond linkage. The prodrugs disclosed herein have extended half lives and are converted to the active form at physiological conditions through a non-enzymatic reaction driven by chemical instability.

The present invention provides a method for the treatment and/or prevention of bacterial infection caused by Enterobacteriaceae in central nervous system and/or peripheral blood circulation in a mammal by administering effective amount of outer membrane protein A (OmpA) or its derivatives to a mammal. Also provided are a method for vaccinating a mammal to produce an antibody against bacterial infe...

The present invention is directed to therapeutic methods using IL-6 antagonists such as antibodies and fragments thereof having binding specificity for IL-6 to improve survivability or quality of life of a patient in need thereof. In preferred embodiments, the anti-IL-6 antibodies will be humanized and/or will be aglycosylated. Also, in preferred embodiments these patients will comprise those exhi...